SR
Therapeutic Areas
CatalYm Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Visugromab (CTL-002) | Metastatic Non-squamous Non-Small Cell Lung Cancer (2nd line) | Phase 2b |
| Drug | Indication | Phase |
|---|---|---|
| Visugromab (CTL-002) | Metastatic Non-squamous Non-Small Cell Lung Cancer (2nd line) | Phase 2b |